Need Help?

Paired exome and low-coverage genome sequencing of osteosarcoma

We perform longitudinal genome-sequencing analysis of 12 patients with metastatic or refractory osteosarcoma. The study was approved at the University Hospital Basel, following the approval of the ethical committee for mutational analysis of anonymized samples (“Ethikkommission beider Basel” ref. 274/12). All tumor samples were evaluated by an experienced bone pathologist to confirm the diagnosis.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001007509 Illumina HiSeq 4000 72
Publications Citations
The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies.
J Pathol 254: 2021 556-566
7